
Immunic Inc (IMUX) Earnings Dates & Reports
Immunic Inc (IMUX) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.18
Actual EPS-$0.13
EarningsBeat
Immunic Inc (IMUX) Earnings
View the latest Immunic Inc (IMUX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Immunic Inc (IMUX)
Order type
Buy in
Order amount
Est. shares
0 shares
Immunic Inc (IMUX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Immunic Inc (IMUX) Latest Earnings
The value each IMUX share was expected to gain vs. the value each share gained.
Immunic Inc (IMUX) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.13. This exceeded analysts' expectations of -$0.18 by 27.78%, marking a Beat.
For comparison, Immunic Inc reported EPS of -$0.24 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.10.
Immunic Inc (IMUX) Earnings History
Immunic Inc (IMUX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Immunic Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Immunic Inc (IMUX) Earnings FAQs
Immunic Inc (IMUX) last reported earnings on Nov 13, 2025 for Q3 2025, posting an EPS of -$0.13, which Beat the estimate of -$0.18 by 27.78%.
For Q3 2025, Immunic Inc (IMUX) reported an EPS of -$0.13, exceeding analysts' estimate of -$0.18 by 27.78%.
For Q3 2025, Immunic Inc (IMUX) Beat expectations with an actual EPS of -$0.13 vs. an estimated EPS of -$0.18.
Following the last earnings report on Nov 13, 2025, Immunic Inc (IMUX)'s stock price moved — from — to —.
The next Immunic Inc (IMUX) earnings call is scheduled for Feb. 14, 2026, where executives will discuss financial results and outlook.